Corify

Corify Care SL is a Spanish medical start-up focused on diagnosing and treating cardiac arrhythmias, particularly atrial fibrillation (AF). Founded by a team of biomedical engineers and cardiac physiologists, the company emerged from research at Hospital Universitario Gregorio Marañón and Universitat Politècnica de València. Corify aims to help clinicians visualize the heart effectively to enhance patient outcomes and aspires to be a global leader in arrhythmia treatment. The company has developed ACORYS, a non-invasive cardiac mapping system that utilizes 128 body surface sensors to create detailed electroanatomic maps of the heart. This innovative technology improves diagnosis accuracy and assists surgeons during ablation procedures, leading to better clinical outcomes and reduced healthcare costs. Corify's solutions integrate digital twins and AI to further personalize cardiac mapping and treatment. With plans for expansion into Europe and the US, Corify is committed to meeting the needs of healthcare providers specializing in cardiac electrophysiology.

• Employees 28
• Founded 2019
• Annual Revenue $1900000
• Total Funding $8392648